Completion of Collaboration Agreement

20 May 2013

 RECKITT BENCKISER ANNOUNCES COMPLETION OF LATAM OTC COLLABORATION AGREEMENT   
                           WITH BRISTOL-MYERS SQUIBB                           

Slough, England - 20 May, 2013 - Reckitt Benckiser Group PLC ("RB") (LSE: RBL)
announces that the three year collaboration agreement signed with Bristol-Myers
Squibb Company (NYSE: BMY) on 10 February 2013 has been completed and that
regulatory approvals, including anti-trust approvals in the relevant
jurisdictions, have now been obtained.

 

The terms of the agreement include the transfer of personnel, supply contracts
and an option to acquire legal title to the related intellectual property at
the end of the collaboration period, based on business performance.  Reckitt
Benckiser will account for the transaction as a business combination.

                                     ENDS                                      

Investor & Analyst Contacts:

Reckitt Benckiser (RB)

Richard Joyce

Director, Investor Relations

[phone]

Media Contacts:

Reckitt Benckiser (RB)

Andraea Dawson-Shepherd

SVP, Global Corporate Communication & Affairs

[phone]

Brunswick (Financial PR)

David Litterick / Max McGahan

[phone]